Time to eliminate Ekso Bionics Holdings Inc. (NASDAQ:EKSO) from your holding?


Shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) last traded at $1.95. (NASDAQ:EKSO) performance year to date is -51.01%. The 200 day simple moving average is -50.80%. The 200 simple moving average (SMA) is considered a key indicator by traders and market analysts for determining the overall long-term trend. The price level in a market that coincides with the 200 SMA is recognized as a major support when price is above the 200 SMA or resistance when price is below the 200 SMA level.

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company’s operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has been in the news for all the right reasons. Recently, Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) announced the company plans to participate in the B. Riley & Co. Institutional Investor Conference in Santa Monica, California.

Ekso Bionics’ management is scheduled to present Wednesday, May 24, 2017 at 10:00 a.m. PDT. A live and archived webcast of the presentation will be available on the investors section of the company’s website at: www.eksobionics.com.

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend. The market is approaching oversold territory. Be watchful of a trend reversal.

The Exponential Moving Average (EMA) is similar to a simple moving average (average price over a set period) but it utilizes a weighting factor that exponentially declines from the most recent data point (recent prices are weighted higher than oid prices). EMA analysis compares the short term (5 days and 13 days), intermediate term (20 days) and long term (50 days) EMA’s. The respective EMA’s will give bullish signals when trading above trailing EMA’s and below the current price and vice versa. EMA alerts include crossovers (i.e the 5 day EMA crosses above/below the 20 day EMA) and EMA convergencies (5 day EMA equivalent to 13 day EMA). .

The relative strength index (RSI) is a momentum oscillator that is able to measure the velocity and magnitude of stock price changes. Momentum is calculated as the ratio of positive price changes to negative price changes. The RSI analysis compares the current RSI against neutral(50), oversold (30) and overbought (70) conditions. Alerts will inform you when stocks recede from oversold/overbought levels or breakthrough neutral (50).

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is all set to announce its earnings on May 09/a. As per Zack’s analyst ratings, Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) currently has an average brokerage rating of 1. On a scale of 1 to 5, a rating of 1 or 2 would indicate a buy, and a rating of 4 or 5 would signify a sell recommendation. A rating of 3 would indicate a hold on the stock. The consensus target price on (NASDAQ:EKSO) is $12 with a high of $21 and a low of $4.

As such, while we believe Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) represents a compelling growth story exposed to several secularly attractive markets, it would be interesting to see how it fairs for long-term investors.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.